People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Spasmodic dysphonia impacts about 50,000 people in North America. Here's what to know about what causes spasmodic dysphonia ...

RFK Jr, diagnosed with spasmodic dysphonia, is in the news for his confirmation hearing as the United States Secretary of ...

and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The company has been gaining significant ...

Stock options listed on U.S. stock exchanges generally have a notional amount of 100 shares of stock. Stock options are also traded in the over the counter (OTC) market with variable notional amounts.

NLS Pharmaceutics Ltd.  ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, is pleased to ...

After hours: January 31 at 4:20:00 PM EST Loading Chart for SUPN ...

After hours: January 27 at 5:11:25 PM EST Loading Chart for CNTA ...

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended ...

Viagra might be one of the first options that comes to mind. Since it received FDA approval in 1998, Viagra has been consistently shown to be an effective treatment option for ED. However ...

Trading options can be one of the most lucrative ways to make money in the stock market. But many people miss out on these profits because they believe options are too complex, risky, or that you ...